Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Innovent Biologics, Inc.
  6. SocietÓ
    1801   KYG4818G1010

INNOVENT BIOLOGICS, INC.

(1801)
RiassuntoGraficiNotizieRatingAgendaSocietÓFinanzaConsensusRevisioni 
AttivitÓ
Innovent Biologics, Inc. Ŕ una societÓ biofarmaceutica con sede in Cina. I principali prodotti della societÓ comprendono l'anticorpo PD-1, il bevacizumab (Avastin) biosimilare, IBI-305, il rituximab (MabThera/Rituxan) biosimilare, IBI-301, e l'adalimumab (Humira) biosimilare, IBI-303.

Numero di dipendenti : 3 279 persone.
Vendite per attivitÓ
20192020Delta
Pharmaceutical Products1 187.81100%4 319.27100% +263.63%
HKD in Milioni
Vendite per regione
2020
China2 749.3963.7%
United States1 569.8936.3%
HKD in Milioni
Dirigenti
Nome Titolo EtÓ Da
De Chao Yu Chairman & Chief Executive Officer 57 2020
Yong-Jun Liu President - 2020
Hao Xi Ede Chief Financial Officer & Executive Director 62 -
Jessie Chen Chief Medical Officer - -
Qin Wei Zhou Chief Operations Officer 58 2016
Charles Leland Cooney, Dr. Independent Non-Executive Director 76 2016
I Yin Hsu Independent Non-Executive Director 46 2018
Kai-Xian Chen, Dr. Independent Non-Executive Director 75 2018
Yan Ju Wang Joint Secretary 32 2015
Lok Yee Chan Joint Secretary 31 -
Amministratori
Nome Titolo EtÓ Da
De Chao Yu Chairman & Chief Executive Officer 57 2020
Charles Leland Cooney, Dr. Independent Non-Executive Director 76 2016
Hao Xi Ede Chief Financial Officer & Executive Director 62 -
Shu Yun Chen Non-Executive Director 46 2018
I Yin Hsu Independent Non-Executive Director 46 2018
Kai-Xian Chen, Dr. Independent Non-Executive Director 75 2018
Azionisti
NomeAzioni%
De Chao Yu 108 705 272 7,44%
Temasek Holdings Pte Ltd. (Investment Management) 100 705 350 6,89%
Invesco Advisers, Inc. 79 013 500 5,41%
Capital International Private Equity Funds 50 477 090 3,45%
The Vanguard Group, Inc. 40 756 410 2,79%
Canada Pension Plan Investment Board 37 498 360 2,57%
Fidelity Management & Research Co. LLC 37 177 831 2,54%
FIL Investment Management (Hong Kong) Ltd. 35 966 000 2,46%
Norges Bank Investment Management 23 092 399 1,58%
BlackRock Fund Advisors 23 028 500 1,58%
Coordinate societÓ
Innovent Biologics, Inc.
168 Dongping Street
Suzhou Industrial Park
Suzhou, Jiangsu 215123

Phone : +86.512.69566088
Fax : +1.512.69566088
Web : http://www.innoventbio.com
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Innovent Biologics, Inc.